Hélène Le Guillou-Guillemette

Hélène Le Guillou-Guillemette

Auto-generated profile, based on publicly available information

Hélène Le Guillou-Guillemette

Virology Department, Angers University Hospital, Angers, France; HIFIH Laboratory EA 3859, LUNAM, Angers, France

Research Focus & Metrics

Academic Career Length

21Years (2006-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 August 2020 in Journal of Clinical Virology
Verified
Journal Article
Closed access
TNThomas Nicol
Thomas Nicol
CLCaroline Lefeuvre
Caroline Lefeuvre
OSOrianne Serri
Orianne Serri
APAdeline Pivert
Adeline Pivert
FJFrançoise Joubaud
Françoise Joubaud
HGHélène Le Guillou-Guillemette
Hélène Le Guillou-Guillemette

Verified
Journal Article
Open access
PDF file
CLCaroline Lefeuvre
Caroline Lefeuvre
HGHélène Le Guillou-Guillemette
Hélène Le Guillou-Guillemette
ADAlexandra Ducancelle
Alexandra Ducancelle
Chronic hepatitis B virus (HBV) infection is one of the most common factors associated with hepatocellular carcinoma (HCC), which is the sixth most prevalent cancer among all cancers worldwide. However, the pathogenesis of HBV-mediated hepatocarcinogenesis is unclear. Evidence currently available suggests that the HBV core protein (HBc) plays a potential role in the development of HCC, such as the HBV X protein. The core protein, which is the structural component of the viral nucleocapsid, contributes to almost every stage of the HBV life cycle and occupies diverse roles in HBV replication and pathogenesis. Recent studies have shown that HBc was able to disrupt various pathways involved in liver carcinogenesis: the signaling pathways implicated in migration and proliferation of hepatoma cells, apoptosis pathways, and cell metabolic pathways inducing the development of HCC; and the immune system, through the expression and production of proinflammatory cytokines. In addition, HBc can modulate normal functions of hepatocytes through disrupting human host gene expression by binding to promoter regions. This HBV protein also promotes HCC metastasis through epigenetic alterations, such as micro-RNA. This review focuses on the molecular pathogenesis of the HBc protein in HBV-induced HCC.

27 October 2016 in Journal of Gastroenterology and Hepatology
Verified
Journal Article
Closed access
PDF file
ADAlexandra Ducancelle
Alexandra Ducancelle
APAdeline Pivert
Adeline Pivert
SBSandrine Bertrais
Sandrine Bertrais
JBJérôme Boursier
Jérôme Boursier
VBViorica Balan
Viorica Balan
FLFrançoise Lunel‐Fabiani
Françoise Lunel‐Fabiani

1 January 2010 in Journal of Clinical Virology
Verified
Journal Article
Closed access
WMWael Mansour
Wael Mansour
ADAlexandra Ducancelle
Alexandra Ducancelle
FGFrederic LE GAL
Frederic LE GAL
HGHélène Le Guillou-Guillemette
Hélène Le Guillou-Guillemette
PAPierre Abgueguen
Pierre Abgueguen
FLFrançoise Lunel
Françoise Lunel

24 June 2015 in Journal of Clinical Virology
Verified
Journal Article
Closed access
PDF file
HGH. Le Guillou-Guillemette
H. Le Guillou-Guillemette
ADAlexandra Ducancelle
Alexandra Ducancelle
SBS. Bertrais
S. Bertrais
CLC. Lemaire
C. Lemaire
APA. Pivert
A. Pivert
FFFrançoise Lunel Fabiani
Françoise Lunel Fabiani

1 August 2020 in Journal of Clinical Virology
Verified
Journal Article
Closed access
SRSteven Roger
Steven Roger
CLCaroline Lefeuvre
Caroline Lefeuvre
MGMarine Grison
Marine Grison
ADAlexandra Ducancelle
Alexandra Ducancelle
FLFrançoise Lunel-Fabiani
Françoise Lunel-Fabiani
HGHélène Le Guillou-Guillemette
Hélène Le Guillou-Guillemette